GlassScriptPhysician profile
Randal David Davidson
NPI 1326019225
$2,200.35
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $317 · 2021: $467 · 2022: $534 · 2023: $467 · 2024: $47.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $954.20 | 2019-2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $258.70 | 2019-2022 | |
| Corium, LLC | $184.36 | 2021-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $173.83 | 2021-2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $128.38 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $69.94 | 2022-2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Pfizer INC. | $69.52 | 2019-2023 | |
| Kaleo, INC. | $65.12 | 2020-2023 | Auvi-Q |
| Shire North American Group INC | $61.91 | 2019 | |
| Sanofi Pasteur INC. | $49.92 | 2021-2023 | |
| Glaxosmithkline, LLC. | $47.87 | 2019-2021 | |
| Seqirus USA INC | $30.68 | 2022 | |
| Mirum Pharmaceuticals, INC. | $18.64 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.84 | 2022 | |
| Genentech USA, INC. | $15.71 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.09 | 2019 | |
| Cranial Technologies, INC | $14.66 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.22 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randal Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.